Pharmacotherapy of Sjogren’s syndrome: A comparison of disease activity with Iscalimab and Ianalumab
Crossref DOI link: https://doi.org/10.30574/wjbphs.2024.20.2.0914
Published Online: 2024-11-30
Update policy: https://doi.org/10.30574/wjbphs.ourcrossmarkpolicy
Sultan Akbar,
